Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteria
Objectives: The bacille Calmette-Guérin (BCG) vaccine is usually administered at birth to protect against severe forms of tuberculosis in children. BCG also confers some protection against other infections, possibly mediated by innate immune training. We investigated whether newborn BCG vaccination...
Main Authors: | Melissa Murphy, Sara Suliman, Libby Briel, Helen Veldtsman, Nondumiso Khomba, Hadn Africa, Marcia Steyn, Candice I. Snyders, Ilana C. van Rensburg, Gerhard Walzl, Novel N. Chegou, Mark Hatherill, Willem A. Hanekom, Thomas J. Scriba, Elisa Nemes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971223000693 |
Similar Items
-
Human newborn bacille Calmette–Guérin vaccination and risk of tuberculosis disease: a case-control study
by: Fletcher, H, et al.
Published: (2016) -
Tuberculosis vaccines: beyond bacille Calmette–Guérin
by: McShane, H
Published: (2011) -
Revaccination with Bacille Calmette-Guérin: Some issues to consider
by: Manjula Datta, et al.
Published: (2023-01-01) -
Safety and immunogenicity of newborn MVA85A vaccination and selective, delayed Bacille Calmette-Guerin (BCG) for infants of HIV infected mothers: A phase 2 randomized controlled trial.
by: Nemes, E, et al.
Published: (2017) -
Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants
by: AC Hesseling, et al.
Published: (2009-07-01)